524 related articles for article (PubMed ID: 30890156)
1. Development of drug-inducible CRISPR-Cas9 systems for large-scale functional screening.
Sun N; Petiwala S; Wang R; Lu C; Hu M; Ghosh S; Hao Y; Miller CP; Chung N
BMC Genomics; 2019 Mar; 20(1):225. PubMed ID: 30890156
[TBL] [Abstract][Full Text] [Related]
2. New Developments in CRISPR/Cas-based Functional Genomics and their Implications for Research Using Zebrafish.
Prykhozhij SV; Caceres L; Berman JN
Curr Gene Ther; 2017; 17(4):286-300. PubMed ID: 29173171
[TBL] [Abstract][Full Text] [Related]
3. Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting.
Iorio F; Behan FM; Gonçalves E; Bhosle SG; Chen E; Shepherd R; Beaver C; Ansari R; Pooley R; Wilkinson P; Harper S; Butler AP; Stronach EA; Saez-Rodriguez J; Yusa K; Garnett MJ
BMC Genomics; 2018 Aug; 19(1):604. PubMed ID: 30103702
[TBL] [Abstract][Full Text] [Related]
4. Pooled CRISPR-Based Genetic Screens in Mammalian Cells.
Chan K; Tong AHY; Brown KR; Mero P; Moffat J
J Vis Exp; 2019 Sep; (151):. PubMed ID: 31545321
[TBL] [Abstract][Full Text] [Related]
5. High-throughput genetic screens using CRISPR-Cas9 system.
Kweon J; Kim Y
Arch Pharm Res; 2018 Sep; 41(9):875-884. PubMed ID: 29637495
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9 genome-wide loss-of-function screening identifies druggable cellular factors involved in sunitinib resistance in renal cell carcinoma.
Makhov P; Sohn JA; Serebriiskii IG; Fazliyeva R; Khazak V; Boumber Y; Uzzo RG; Kolenko VM
Br J Cancer; 2020 Dec; 123(12):1749-1756. PubMed ID: 32968206
[TBL] [Abstract][Full Text] [Related]
7. High-throughput functional genomics using CRISPR-Cas9.
Shalem O; Sanjana NE; Zhang F
Nat Rev Genet; 2015 May; 16(5):299-311. PubMed ID: 25854182
[TBL] [Abstract][Full Text] [Related]
8. Parallel CRISPR-Cas9 screens clarify impacts of p53 on screen performance.
Bowden AR; Morales-Juarez DA; Sczaniecka-Clift M; Agudo MM; Lukashchuk N; Thomas JC; Jackson SP
Elife; 2020 May; 9():. PubMed ID: 32441252
[TBL] [Abstract][Full Text] [Related]
9. Large-Scale Single Guide RNA Library Construction and Use for CRISPR-Cas9-Based Genetic Screens.
Wang T; Lander ES; Sabatini DM
Cold Spring Harb Protoc; 2016 Mar; 2016(3):pdb.top086892. PubMed ID: 26933254
[TBL] [Abstract][Full Text] [Related]
10. CRISPR-mediated ablation of overexpressed EGFR in combination with sunitinib significantly suppresses renal cell carcinoma proliferation.
Liu B; Diaz Arguello OA; Chen D; Chen S; Saber A; Haisma HJ
PLoS One; 2020; 15(5):e0232985. PubMed ID: 32413049
[TBL] [Abstract][Full Text] [Related]
11. Genome-scale CRISPR screening at high sensitivity with an empirically designed sgRNA library.
Henkel L; Rauscher B; Schmitt B; Winter J; Boutros M
BMC Biol; 2020 Nov; 18(1):174. PubMed ID: 33228647
[TBL] [Abstract][Full Text] [Related]
12. [Functional genetic screening using CRISPR-Cas9 system].
Li H; Huang C
Sheng Wu Gong Cheng Xue Bao; 2018 Apr; 34(4):461-472. PubMed ID: 29701021
[TBL] [Abstract][Full Text] [Related]
13. Functional genomic screening approaches in mechanistic toxicology and potential future applications of CRISPR-Cas9.
Shen H; McHale CM; Smith MT; Zhang L
Mutat Res Rev Mutat Res; 2015; 764():31-42. PubMed ID: 26041264
[TBL] [Abstract][Full Text] [Related]
14. Identification of oncogenic driver mutations by genome-wide CRISPR-Cas9 dropout screening.
Kiessling MK; Schuierer S; Stertz S; Beibel M; Bergling S; Knehr J; Carbone W; de Vallière C; Tchinda J; Bouwmeester T; Seuwen K; Rogler G; Roma G
BMC Genomics; 2016 Sep; 17(1):723. PubMed ID: 27613601
[TBL] [Abstract][Full Text] [Related]
15. caRpools: an R package for exploratory data analysis and documentation of pooled CRISPR/Cas9 screens.
Winter J; Breinig M; Heigwer F; Brügemann D; Leible S; Pelz O; Zhan T; Boutros M
Bioinformatics; 2016 Feb; 32(4):632-4. PubMed ID: 26508755
[TBL] [Abstract][Full Text] [Related]
16. Editing the Mouse Genome Using the CRISPR-Cas9 System.
Williams A; Henao-Mejia J; Flavell RA
Cold Spring Harb Protoc; 2016 Feb; 2016(2):pdb.top087536. PubMed ID: 26832693
[TBL] [Abstract][Full Text] [Related]
17. A Perspective on the Future of High-Throughput RNAi Screening: Will CRISPR Cut Out the Competition or Can RNAi Help Guide the Way?
Taylor J; Woodcock S
J Biomol Screen; 2015 Sep; 20(8):1040-51. PubMed ID: 26048892
[TBL] [Abstract][Full Text] [Related]
18. iCSDB: an integrated database of CRISPR screens.
Choi A; Jang I; Han H; Kim MS; Choi J; Lee J; Cho SY; Jun Y; Lee C; Kim J; Lee B; Lee S
Nucleic Acids Res; 2021 Jan; 49(D1):D956-D961. PubMed ID: 33137185
[TBL] [Abstract][Full Text] [Related]
19. A large-scale resource for tissue-specific CRISPR mutagenesis in
Port F; Strein C; Stricker M; Rauscher B; Heigwer F; Zhou J; Beyersdörffer C; Frei J; Hess A; Kern K; Lange L; Langner N; Malamud R; Pavlović B; Rädecke K; Schmitt L; Voos L; Valentini E; Boutros M
Elife; 2020 Feb; 9():. PubMed ID: 32053108
[TBL] [Abstract][Full Text] [Related]
20. Identifying synthetic lethal targets using CRISPR/Cas9 system.
Dhanjal JK; Radhakrishnan N; Sundar D
Methods; 2017 Dec; 131():66-73. PubMed ID: 28710008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
